INCR (intercure.co) יחס שווי שוק לשווי בספרים

This daily price chart for InterCure Ltd. (INCR), serving as the primary valuation tool, reflects the price action of an asset currently valued at 0.37. The business relies on global alliances with pharmaceutical suppliers in Israel and Europe. InterCure Ltd. (INCR) focuses on the production of ultra-pure cannabinoids and cultivation automation. The current strategic trajectory is based on expanding its overseas pharmacy network while maintaining strict control over internal costs.

Global distribution of pharmaceutical cannabis through pharmacy chains creates a sustainable value base for InterCure Ltd. (INCR). By analyzing the dynamics of the price-to-book ratio, one can assess the gap between the market price and actual net assets. This metric compares market capitalization with book value, revealing the extent to which the business is undervalued or overpriced. This allows investors to distinguish a favorable entry point from a "value trap." It is critical for investors to consider asset quality when this indicator declines.